Veeva Systems (VEEV) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
CFRA Upgrades Veeva Systems (VEEV) to Buy Amid Sell-Off
March 3, 2022 11:09 AM ESTCFRA upgraded Veeva Systems (NYSE: VEEV) from Hold to Buy.
The analyst commented, "Following a steep sell-off after VEEV reiterated a slower FY 23 sales outlook, we upgrade our view to Buy from Hold, as we already anticipated challenges with higher wages and... More
Veeva Systems (VEEV) PT Lowered to $250 at FBN Securities, 'Attractive on Pullback'
March 3, 2022 10:47 AM ESTFBN Securities analyst Shebly Seyrafi lowered the price target on Veeva Systems (NYSE: VEEV) to $250.00 (from $320.00) while maintaining a Outperform rating.
"VEEVAttractive Valuation After the Pull-Back"... MoreVeeva Systems (VEEV) PT Lowered to $270 at Needham & Company
March 3, 2022 6:33 AM ESTNeedham & Company analyst Ryan MacDonald lowered the price target on Veeva Systems (NYSE: VEEV) to $270.00 (from $327.00) while maintaining a Buy rating following results, saying a larger R&D opportunity make FY23 back-half weighted.
The analyst commented, "We reiterate our Buy rating, while... More
